Although <i>IGH/MYC</i> translocation in association with dysregulation of antiapoptotic pathway leads to worse prognosis in lymphomas, the novel agent-based regimen showed good efficacy, suggesting that <i>IGH/MYC</i> plays a different role in the pathogenesis of MM. This evidence concerns the gene MYC and Miyoshi myopathy.